Compare key investment metrics of 310210 and 대웅제약 in real time. Both stocks belong to the 치매 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- By market capitalization, 310210 is larger — ₩3.1T vs 대웅제약's ₩1.5T. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- 310210's current price of 171,000원 sits at about 24% of its 52-week range (106,600원–375,500원).
- 대웅제약's current price of 133,300원 sits at about 27% of its 52-week range (105,000원–208,000원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | 310210 | 대웅제약 |
|---|---|---|
| Price | 171,000원 | 133,300원 |
| PER | - | 7.73배 |
| PBR | 34.13배 | 1.49배 |
| Dividend Yield | - | 0.45% |
| Market Cap | ₩3.1T | ₩1.5T |
| 52-Week High | 375,500원 | 208,000원 |
| 52-Week Low | 106,600원 | 105,000원 |
As of 2026-07-06 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, 310210 or 대웅제약?
PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share. A lower PER may suggest the stock is undervalued relative to its earnings. Since PER changes with each earnings report, check the real-time comparison table on this page for the latest 310210 and 대웅제약 PER values.
What is the dividend yield difference between 310210 and 대웅제약?
Dividend yield measures annual dividends as a percentage of the stock price. A higher yield means more cash income per dollar invested. The dividend yields of 310210 and 대웅제약 fluctuate with dividend policy changes and stock price movements — check this page's live data for the most current comparison.
How to compare 310210 and 대웅제약?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.